newsroom

February 21, 2012
Marshall Edwards Announces Rights Offering to Stockholders
[ View full article ]
January 3, 2012
Marshall Edwards Issued New Method of Use Patent for Lead Oncology Drug Candidate ME-344
[ View full article ]